O
NKTX icon

OrbiMed’s Nkarta NKTX Stock Holding History

OrbiMed’s Portfolio NKTX Stock Details NKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-821,400
Closed -$1.51M – 110
2025
Q1 		$1.51M Hold
821,400
– – 0.04% 96
2024
Q4 		$2.05M Sell
821,400
-659,200
-45% -$2.03M 0.04% 101
2024
Q3 		$6.69M Buy
1,480,600
+680,600
+85% +$3.87M 0.12% 88
2024
Q2 		$4.73M Hold
800,000
– – 0.09% 91
2024
Q1 		$8.65M Buy
+800,000
New +$8.32M 0.16% 85

Other funds holding NKTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed's NKTX Position: Q2 2025 in Review

OrbiMed sold out of Nkarta (NKTX) in Q2 2025, closing a stake of 821,400 shares — an estimated $1.51M sold.

OrbiMed first reported a position in NKTX in Q1 2024 and held it in 5 quarters. The position peaked at $8.65M in Q1 2024. 104 funds tracked by Wall St. Rank hold NKTX as of Q2 2025.

  • OrbiMed reported no remaining Nkarta position as of Q2 2025 after selling out during the quarter.
  • OrbiMed sold 821,400 Nkarta shares in Q2 2025, an estimated $1.51M.
  • OrbiMed first reported a position in Nkarta in Q1 2024 and held it in 5 quarters.
  • OrbiMed's Nkarta position peaked at $8.65M in Q1 2024.
  • 104 funds tracked by Wall St. Rank held Nkarta as of Q2 2025.

Based on OrbiMed's 13F filing for Q2 2025, filed 14 Aug 2025.